1 |
Bordbar M, Jam N, Karimi M, Shahriari M, Zareifar S, Zekavat OR, Haghpanah S, Mottaghipisheh H. The survival of childhood leukemia: An 8-year single-center experience. Cancer Rep (Hoboken) 2023;:e1784. [PMID: 36700480 DOI: 10.1002/cnr2.1784] [Reference Citation Analysis]
|
2 |
Reschke A, Richards RM, Smith SM, Long AH, Marks LJ, Schultz L, Kamens JL, Aftandilian C, Davis KL, Gruber T, Sakamoto KM. Development of clinical pathways to improve multidisciplinary care of high-risk pediatric oncology patients. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1033993] [Reference Citation Analysis]
|
3 |
Cotorogea-Simion M, Pavel B, Isac S, Telecan T, Matache IM, Bobirca A, Bobirca FT, Rababoc R, Droc G. What Is Different in Acute Hematologic Malignancy-Associated ARDS? An Overview of the Literature. Medicina (Kaunas) 2022;58:1215. [PMID: 36143892 DOI: 10.3390/medicina58091215] [Reference Citation Analysis]
|
4 |
van der Velde MGAM, Tiellemans SMB, de Lil H, Nieuwenhuizen L. The value of leukapheresis for treatment of priapism as presenting feature of chronic myeloid leukemia—Case report and review of literature. eJHaem 2022. [DOI: 10.1002/jha2.545] [Reference Citation Analysis]
|
5 |
Rinaldi I, Sutandyo N, Winston K. Comparison of early mortality between leukapheresis and non-leukapheresis in adult acute myeloid leukemia patients with hyperleukocytosis: a systematic review and meta-analysis. Hematology 2022;27:141-9. [DOI: 10.1080/16078454.2021.2024939] [Reference Citation Analysis]
|